Viewing StudyNCT00328120



Ignite Creation Date: 2024-05-05 @ 4:51 PM
Last Modification Date: 2024-10-26 @ 9:25 AM
Study NCT ID: NCT00328120
Status: COMPLETED
Last Update Posted: 2010-11-17
First Post: 2006-05-18

Brief Title: Faslodex 500mg Multiple Dose Tolerability Study in BC Patients
Sponsor: AstraZeneca
Organization: AstraZeneca

Organization Data

Organization: AstraZeneca
Class: INDUSTRY
Study ID: D6995C00004
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: AstraZeneca
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators